Editorial: Sphingolipids in cardiovascular diseases: from pathogenesis to therapeutics

被引：0
|
作者：
Collino, Massimo [1 ]
Piccoli, Marco [2 ,3 ]
机构：
[1] Univ Turin, Dept Neurosci Rita Levi Montalcini, Turin, Italy
[2] IRCCS Policlin San Donato, Lab Stem Cells Tissue Engn, San Donato Milanese, Italy
[3] Inst Mol & Translat Cardiol IMTC, San Donato Milanese, Milan, Italy
来源：
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2024年 / 10卷
关键词：
sphingolipid; cardiovascular disease; ceramide; S1P; molecular target;
D O I：
10.3389/fcvm.2023.1330274
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases
    Bhat, Owais Mohmad
    Mir, Rakeeb Ahmad
    Nehvi, Iqra Bashir
    Wani, Nissar Ahmad
    Dar, Abid Hamid
    Zargar, M. Afzal
    IJC HEART & VASCULATURE, 2024, 53
  • [2] Editorial: Microglial Polarization in the Pathogenesis and Therapeutics of Neurodegenerative Diseases
    Tang, Yu
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [3] Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
    Qin, Cheng Xue
    Woodman, Owen L.
    Leo, Chen Huei
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [4] Editorial: Sphingolipids in infections, diseases, and disorders
    Naz, Farha
    Arish, Mohd
    Hassan, Imtaiyaz
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases
    Qin, Yanwen
    Shi, Guo-Ping
    PHARMACOLOGY & THERAPEUTICS, 2011, 131 (03) : 338 - 350
  • [6] Editorial: Highlights for Cardiovascular Therapeutics in 2021 - Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
    Yang, William Y.
    Nguyen, Bonnie
    Wu, Sheng
    Yu, Jun
    Wang, Hong
    Yang, Xiaofeng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] The therapeutic potential of sphingolipids for cardiovascular diseases
    Bar, Sapir Ya'ar
    Pintel, Noam
    Abd Alghne, Hesen
    Khattib, Hamdan
    Avni, Dorit
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [8] The role of sphingolipids in selected cardiovascular diseases
    Kurek, Krzysztof
    Piotrowska, Dominika M.
    Wiesiolek-Kurek, Patrycja
    Chabowska, Anna
    Lukaszuk, Bartlomiej
    Zendzian-Piotrowska, Malgorzata
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2013, 67 : 1018 - 1026
  • [9] Sphingolipids in cardiovascular diseases and metabolic disorders
    Borodzicz, Sonia
    Czarzasta, Katarzyna
    Kuch, Marek
    Cudnoch-Jedrzejewska, Agnieszka
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [10] Sphingolipids in cardiovascular diseases and metabolic disorders
    Sonia Borodzicz
    Katarzyna Czarzasta
    Marek Kuch
    Agnieszka Cudnoch-Jedrzejewska
    Lipids in Health and Disease, 14
12345